These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 26763073)

  • 1. Screening of PRKAR1A and PDE4D in a Large Italian Series of Patients Clinically Diagnosed With Albright Hereditary Osteodystrophy and/or Pseudohypoparathyroidism.
    Elli FM; Bordogna P; de Sanctis L; Giachero F; Verrua E; Segni M; Mazzanti L; Boldrin V; Toromanovic A; Spada A; Mantovani G
    J Bone Miner Res; 2016 Jun; 31(6):1215-24. PubMed ID: 26763073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What to consider when pseudohypoparathyroidism is ruled out: iPPSD and differential diagnosis.
    Pereda A; Garin I; ; Perez de Nanclares G
    BMC Med Genet; 2018 Mar; 19(1):32. PubMed ID: 29499646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Genes in the cAMP pathway causing skeletal dysplasia with or without hormonal resistance].
    Silve C
    Biol Aujourdhui; 2016; 210(3):167-170. PubMed ID: 27813477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of novel pathogenic variants and features in patients with pseudohypoparathyroidism and acrodysostosis, subtypes of the newly classified inactivating PTH/PTHrP signaling disorders.
    Truelove A; Mulay A; Prapa M; Casey RT; Adler AI; Offiah AC; Poole KES; Trotman J; Al Hasso N; Park SM
    Am J Med Genet A; 2019 Jul; 179(7):1330-1337. PubMed ID: 31041856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PRKAR1A mutation affecting cAMP-mediated G protein-coupled receptor signaling in a patient with acrodysostosis and hormone resistance.
    Nagasaki K; Iida T; Sato H; Ogawa Y; Kikuchi T; Saitoh A; Ogata T; Fukami M
    J Clin Endocrinol Metab; 2012 Sep; 97(9):E1808-13. PubMed ID: 22723333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PRKAR1A and PDE4D mutations cause acrodysostosis but two distinct syndromes with or without GPCR-signaling hormone resistance.
    Linglart A; Fryssira H; Hiort O; Holterhus PM; Perez de Nanclares G; Argente J; Heinrichs C; Kuechler A; Mantovani G; Leheup B; Wicart P; Chassot V; Schmidt D; Rubio-Cabezas Ó; Richter-Unruh A; Berrade S; Pereda A; Boros E; Muñoz-Calvo MT; Castori M; Gunes Y; Bertrand G; Bougnères P; Clauser E; Silve C
    J Clin Endocrinol Metab; 2012 Dec; 97(12):E2328-38. PubMed ID: 23043190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudohypoparathyroidism and GNAS epigenetic defects: clinical evaluation of albright hereditary osteodystrophy and molecular analysis in 40 patients.
    Mantovani G; de Sanctis L; Barbieri AM; Elli FM; Bollati V; Vaira V; Labarile P; Bondioni S; Peverelli E; Lania AG; Beck-Peccoz P; Spada A
    J Clin Endocrinol Metab; 2010 Feb; 95(2):651-8. PubMed ID: 20061437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characterization and identification of two novel mutations of the GNAS gene in patients with pseudohypoparathyroidism and pseudopseudohypoparathyroidism.
    Jin HY; Lee BH; Choi JH; Kim GH; Kim JK; Lee JH; Yu J; Yoo JH; Ko CW; Lim HH; Chung HR; Yoo HW
    Clin Endocrinol (Oxf); 2011 Aug; 75(2):207-13. PubMed ID: 21521295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pseudohypoparathyroidism type Ia and pseudo-pseudohypoparathyroidism: the growing spectrum of GNAS inactivating mutations.
    Elli FM; deSanctis L; Ceoloni B; Barbieri AM; Bordogna P; Beck-Peccoz P; Spada A; Mantovani G
    Hum Mutat; 2013 Mar; 34(3):411-6. PubMed ID: 23281139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudohypoparathyroidism type Ib in 2015.
    Mantovani G; Elli FM
    Ann Endocrinol (Paris); 2015 May; 76(2):101-4. PubMed ID: 25910998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expanding the phenotypic spectrum of variants in PDE4D/PRKAR1A: from acrodysostosis to acroscyphodysplasia.
    Michot C; Le Goff C; Blair E; Blanchet P; Capri Y; Gilbert-Dussardier B; Goldenberg A; Henderson A; Isidor B; Kayserili H; Kinning E; Le Merrer M; Lyonnet S; Odent S; Simsek-Kiper PO; Quelin C; Savarirayan R; Simon M; Splitt M; Verhagen JMA; Verloes A; Munnich A; Baujat G; Cormier-Daire V
    Eur J Hum Genet; 2018 Nov; 26(11):1611-1622. PubMed ID: 30006632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gsα activity is reduced in erythrocyte membranes of patients with psedohypoparathyroidism due to epigenetic alterations at the GNAS locus.
    Zazo C; Thiele S; Martín C; Fernandez-Rebollo E; Martinez-Indart L; Werner R; Garin I; ; Hiort O; Perez de Nanclares G
    J Bone Miner Res; 2011 Aug; 26(8):1864-70. PubMed ID: 21351142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative analysis of methylation defects and correlation with clinical characteristics in patients with pseudohypoparathyroidism type I and GNAS epigenetic alterations.
    Elli FM; de Sanctis L; Bollati V; Tarantini L; Filopanti M; Barbieri AM; Peverelli E; Beck-Peccoz P; Spada A; Mantovani G
    J Clin Endocrinol Metab; 2014 Mar; 99(3):E508-17. PubMed ID: 24423294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterozygous mutations in cyclic AMP phosphodiesterase-4D (PDE4D) and protein kinase A (PKA) provide new insights into the molecular pathology of acrodysostosis.
    Kaname T; Ki CS; Niikawa N; Baillie GS; Day JP; Yamamura K; Ohta T; Nishimura G; Mastuura N; Kim OH; Sohn YB; Kim HW; Cho SY; Ko AR; Lee JY; Kim HW; Ryu SH; Rhee H; Yang KS; Joo K; Lee J; Kim CH; Cho KH; Kim D; Yanagi K; Naritomi K; Yoshiura K; Kondoh T; Nii E; Tonoki H; Houslay MD; Jin DK
    Cell Signal; 2014 Nov; 26(11):2446-59. PubMed ID: 25064455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acrodysostosis syndromes.
    Silve C; Le-Stunff C; Motte E; Gunes Y; Linglart A; Clauser E
    Bonekey Rep; 2012 Nov; 1():225. PubMed ID: 24363928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pseudohypoparathyroidism and Gsα-cAMP-linked disorders: current view and open issues.
    Mantovani G; Spada A; Elli FM
    Nat Rev Endocrinol; 2016 Jun; 12(6):347-56. PubMed ID: 27109785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic and epigenetic alterations in the GNAS locus and clinical consequences in Pseudohypoparathyroidism: Italian common healthcare pathways adoption.
    de Sanctis L; Giachero F; Mantovani G; Weber G; Salerno M; Baroncelli GI; Elli MF; Matarazzo P; Wasniewska M; Mazzanti L; Scirè G; Tessaris D;
    Ital J Pediatr; 2016 Nov; 42(1):101. PubMed ID: 27871293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent PRKAR1A mutation in acrodysostosis with hormone resistance.
    Linglart A; Menguy C; Couvineau A; Auzan C; Gunes Y; Cancel M; Motte E; Pinto G; Chanson P; Bougnères P; Clauser E; Silve C
    N Engl J Med; 2011 Jun; 364(23):2218-26. PubMed ID: 21651393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current Nomenclature of Pseudohypoparathyroidism: Inactivating Parathyroid Hormone/Parathyroid Hormone-Related Protein Signaling Disorder.
    Turan S
    J Clin Res Pediatr Endocrinol; 2017 Dec; 9(Suppl 2):58-68. PubMed ID: 29280743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetics and epigenetics of parathyroid hormone resistance.
    Bastepe M
    Endocr Dev; 2013; 24():11-24. PubMed ID: 23392091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.